Charles Li
Director/Board Member presso EKSO BIONICS HOLDINGS, INC.
Patrimonio netto: 37 275 $ in data 31/03/2024
Profilo
Charles Li is currently an Independent Director at Ekso Bionics Holdings, Inc. and the Chief Business Officer at Angel Pharmaceuticals Co., Ltd.
He holds a doctorate degree from Harvard University and an undergraduate degree from Xi'an Jiaotong University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/04/2023 | 27 408 ( 0.15% ) | 37 275 $ | 31/03/2024 |
Posizioni attive di Charles Li
| Società | Posizione | Inizio |
|---|---|---|
| EKSO BIONICS HOLDINGS, INC. | Director/Board Member | 11/03/2018 |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 10/10/2020 |
Formazione di Charles Li
| Harvard University | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EKSO BIONICS HOLDINGS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Charles Li
